Dr. Öğr. Üyesi Melek YILDIZ

Desteklenen Projeler

• 2021 - 2026 A Phase II, randomised, multi–centric, multi-national clinical trial to evaluate the efficacy, tolerability and safety of a fixed dose combination of Spironolactone/Pioglitazone/Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS)

  UFUK 2020 Projesi

  (Proje Özeti)

  Darendeliler F. F., Baş F., Yıldız M.